Evidence map›Paper›PMID 27977780›Full record

ArticlePloS one2016

Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion.

Andrew S Gilder, Lei Wang, Letizia Natali, Nicki Karimi-Mostowfi, Coralie Brifault, Steven L Gonias

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. G protein inhibitory α subunit 2 is a molecular oncotarget of human glioma.International journal of biological sciences · 2023
    Article
  4. Toxins · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Andrew S GilderDepartment of Pathology, University of California San Diego, La Jolla CA, United States of America.ORCID http://orcid.org/0000-0002-3938-4086
Lei WangDepartment of Pathology, University of California San Diego, La Jolla CA, United States of America.
Letizia NataliDepartment of Pathology, University of California San Diego, La Jolla CA, United States of America.
Nicki Karimi-MostowfiDepartment of Pathology, University of California San Diego, La Jolla CA, United States of America.
Coralie BrifaultDepartment of Pathology, University of California San Diego, La Jolla CA, United States of America.
Steven L GoniasDepartment of Pathology, University of California San Diego, La Jolla CA, United States of America.
University of California San Diego · USUniversity of Pisa · ITXuzhou Medical College · CN

Funding

Targeting the Urokinase Receptor in Glioblastoma MultiformeR01CA169096 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GONIAS, STEVEN L. · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA169096
6 · The paper itself

Abstract

In high grade glioma (HGG), extensive tumor cell infiltration of normal brain typically precludes identifying effective margins for surgical resection or irradiation. Pertussis toxin (PT) is a multimeric complex that inactivates diverse Gi/o G-protein coupled receptors (GPCRs). Despite the broad continuum of regulatory events controlled by GPCRs, PT may be applicable as a therapeutic. We have shown that the urokinase receptor (uPAR) is a major driver of HGG cell migration. uPAR-initiated cell-signaling requires a Gi/o GPCR, N-formyl Peptide Receptor 2 (FPR2), as an essential co-receptor and is thus, PT-sensitive. Herein, we show that PT robustly inhibits migration of three separate HGG-like cell lines that express a mutated form of the EGF Receptor (EGFR), EGFRvIII, which is constitutively active. PT also almost completely blocked the ability of HGG cells to invade Matrigel. In the equivalent concentration range (0.01-1.0 μg/mL), PT had no effect on cell survival and only affected proliferation of one cell line. Neutralization of EGFRvIII expression in HGG cells, which is known to activate uPAR-initiated cell-signaling, promoted HGG cell migration. The increase in HGG cell migration, induced by EGFRvIII neutralization, was entirely blocked by silencing FPR2 gene expression or by treating the cells with PT. When U87MG HGG cells were cultured as suspended neurospheres in serum-free, growth factor-supplemented medium, uPAR expression was increased. HGG cells isolated from neurospheres migrated through Transwell membranes without loss of cell contacts; this process was inhibited by PT by >90%. PT also inhibited expression of vimentin by HGG cells; vimentin is associated with epithelial-mesenchymal transition and worsened prognosis. We conclude that PT may function as a selective inhibitor of HGG cell migration and invasion.

Indexed as

Cell Line, TumorCell MovementCell ProliferationCell SurvivalErbB ReceptorsGliomaHumansMicroscopy, FluorescencePertussis ToxinReceptors, Formyl PeptideReceptors, G-Protein-CoupledReceptors, LipoxinErbB ReceptorsFPR2 protein, humanPertussis ToxinReceptors, Formyl PeptideReceptors, G-Protein-CoupledReceptors, Lipoxin

Identifiers

PMID27977780
PMCPMC5158192
OpenAlexW2562351036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.